After breast cancer treatment, many women are prescribed aromatase inhibitors to prevent recurrence of estrogen sensitive tumors. These drugs can cause joint pain that leads many women to stop using them, thus increasing their risk of a recurrence.
Read Whole Story
Get top stories and blog posts emailed to me each day. Newsletters may offer personalized content or advertisements. Learn more.